Level B· Emerging clinical evidence with positive signalsClinical TrialEurope PMCOpen access

Facial Overfilled Syndrome: A Narrative Clinical Review

Zhou C., Che Q., Zhao R., Wang H., Wa Q.

Clinical Trial on Face & Skin, published in Clin Cosmet Investig Dermatol (2026) — summary generated from the PubMed abstract.

Open my reading list
Level B· Emerging clinical evidence with positive signalsEvidence level of this study

Several human studies show positive signals, while research methods and sample sizes continue to develop.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Clinical Trial
Journal
Clin Cosmet Investig Dermatol (2026)
Reported sample size
—
Source database
Europe PMC
PMID
41948082
PMCID
PMC13051189
DOI
10.2147/ccid.s600459

Abstract (original English)

Background Facial Overfilled Syndrome (FOS) is an increasingly prevalent iatrogenic complication resulting from the excessive or inappropriate use of dermal fillers. Clinically significant for causing facial distortion and unnatural dynamics, it is frequently compounded by profound psychological distress and aesthetic perception biases. Aim This narrative clinical review aims to summarize the etiology, clinical features, diagnostic approaches, and management strategies of FOS, establishing a structured framework to emphasize the importance of prevention through anatomical knowledge and individualized treatment planning. Methods A comprehensive literature search was conducted in PubMed, Google Scholar, and CNKI using keywords such as "facial overfilled syndrome", "facial overfilling", "overfilled face" and "dermal filler complications". Relevant original studies, clinical trials, meta-analyses, and reviews published until October 2025 were included and synthesized into a narrative framework. Results The pathogenesis of FOS extends beyond mere volumetric excess, driven by a complex triad of anatomical mismatch, biomechanical dysregulation, and the cumulative payload of repeated treatments. Clinical hallmarks include resting distortion and unnatural facial animation. Management must be highly individualized; while targeted, ultrasound-guided hyaluronidase injection remains the est

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.

Evidence level

Several human studies show positive signals, while research methods and sample sizes continue to develop.

How we grade evidence

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research